HEADER TRANSFERASE 11-MAR-22 7Z6A TITLE CRYSTAL STRUCTURE OF WEISSELLA VIRIDESCENS FEMXVV NON-RIBOSOMAL AMINO TITLE 2 ACID TRANSFERASE IN COMPLEX WITH A PEPTIDYL-XNA CONJUGATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: UDP-N-ACETYLMURAMOYLPENTAPEPTIDE-LYSINE N(6)- COMPND 3 ALANYLTRANSFERASE; COMPND 4 CHAIN: A; COMPND 5 EC: 2.3.2.10; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: UDP-MURNAC-PENTAPEPTIDE; COMPND 9 CHAIN: C; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: 2'F-RNA (5'-D(*(GF2)P*(GF2)P*(CFZ)P*(CFZ)P*(AF2)P*(CFZ) COMPND 13 P*(CFZ))-R(P*(A9Z))-3'); COMPND 14 CHAIN: B; COMPND 15 ENGINEERED: YES; COMPND 16 OTHER_DETAILS: 8-NT PEPTIDYL-OLIGONUCLEOTIDE BI-SUBSTRATE ANALOG WITH COMPND 17 2-DEOXY-2-FLUORO RIBONUCLEIC ACIDS, RESIDUES GF2 B 2 AND GFZ B 5 ARE COMPND 18 LINKED BY A POLYETHYLENE GLYCOL NOT OBSERVED IN THE CRYSTAL STRUCTURE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: WEISSELLA VIRIDESCENS; SOURCE 3 ORGANISM_TAXID: 1629; SOURCE 4 GENE: FEMX; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 10 ORGANISM_TAXID: 32630; SOURCE 11 MOL_ID: 3; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 14 ORGANISM_TAXID: 32630 KEYWDS FEMX, XENO-NUCLEIC ACIDS, PEPTIDOGLYCAN, TRANSFERASE, PEPTIDYL-XNA KEYWDS 2 CONJUGATE, TRANSFERASE-PEPTIDE-XNA COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR I.LI DE LA SIERRA-GALLAY REVDAT 6 09-OCT-24 7Z6A 1 REMARK REVDAT 5 31-JAN-24 7Z6A 1 REMARK REVDAT 4 14-DEC-22 7Z6A 1 JRNL REVDAT 3 07-DEC-22 7Z6A 1 COMPND SOURCE REMARK DBREF REVDAT 3 2 1 SEQRES LINK ATOM REVDAT 2 23-NOV-22 7Z6A 1 JRNL REVDAT 1 26-OCT-22 7Z6A 0 JRNL AUTH L.RIETMEYER,I.LI DE LA SIERRA-GALLAY,G.SCHEPERS,D.DORCHENE, JRNL AUTH 2 L.IANNAZZO,D.PATIN,T.TOUZE,H.VAN TILBEURGH,P.HERDEWIJN, JRNL AUTH 3 M.ETHEVE-QUELQUEJEU,M.FONVIELLE JRNL TITL AMINO-ACYL TXNA AS INHIBITORS OR AMINO ACID DONORS IN JRNL TITL 2 PEPTIDE SYNTHESIS. JRNL REF NUCLEIC ACIDS RES. V. 50 11415 2022 JRNL REFN ESSN 1362-4962 JRNL PMID 36350642 JRNL DOI 10.1093/NAR/GKAC1023 REMARK 2 REMARK 2 RESOLUTION. 1.66 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20_4459 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.66 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.44 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 40341 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2018 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 41.4400 - 4.0000 1.00 2807 148 0.1580 0.1497 REMARK 3 2 4.0000 - 3.1800 1.00 2762 146 0.1695 0.2007 REMARK 3 3 3.1700 - 2.7700 1.00 2763 145 0.2036 0.2353 REMARK 3 4 2.7700 - 2.5200 1.00 2763 146 0.2102 0.2769 REMARK 3 5 2.5200 - 2.3400 1.00 2713 142 0.2031 0.2652 REMARK 3 6 2.3400 - 2.2000 1.00 2732 144 0.2022 0.2308 REMARK 3 7 2.2000 - 2.0900 1.00 2778 147 0.1971 0.2550 REMARK 3 8 2.0900 - 2.0000 1.00 2753 145 0.2041 0.2250 REMARK 3 9 2.0000 - 1.9200 1.00 2745 144 0.2212 0.2994 REMARK 3 10 1.9200 - 1.8600 1.00 2743 145 0.2459 0.3125 REMARK 3 11 1.8600 - 1.8000 1.00 2760 144 0.2569 0.2877 REMARK 3 12 1.8000 - 1.7500 1.00 2704 143 0.2830 0.2907 REMARK 3 13 1.7500 - 1.7000 1.00 2733 143 0.2962 0.3583 REMARK 3 14 1.7000 - 1.6600 0.92 2567 136 0.3616 0.3790 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.241 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.702 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.62 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.79 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 3013 REMARK 3 ANGLE : 1.260 4124 REMARK 3 CHIRALITY : 0.070 451 REMARK 3 PLANARITY : 0.007 519 REMARK 3 DIHEDRAL : 17.668 1137 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7Z6A COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-MAR-22. REMARK 100 THE DEPOSITION ID IS D_1292121564. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-OCT-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.980131 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40415 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.660 REMARK 200 RESOLUTION RANGE LOW (A) : 41.440 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.9300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.66 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 4II9 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.26 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.09 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: TRI-NA CITRATE , AMMONIUM ACETATE, PEG REMARK 280 4000, PH 5.6, VAPOR DIFFUSION, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 50.44000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 ASP A 135 REMARK 465 LYS A 334 REMARK 465 ASP A 335 REMARK 465 GLY A 336 REMARK 465 HIS A 337 REMARK 465 HIS A 338 REMARK 465 HIS A 339 REMARK 465 HIS A 340 REMARK 465 HIS A 341 REMARK 465 HIS A 342 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 N ALA C 3 O10 MUB C 101 2.14 REMARK 500 O THR A 66 O HOH A 501 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 79 176.74 173.10 REMARK 500 ASN A 130 -108.13 -150.88 REMARK 500 VAL A 133 -167.99 -120.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7Z5Y RELATED DB: PDB REMARK 900 7Z5Y CONTAINS THE SAME PROTEIN COMPLEXED WITH A 8-NT PEPTIDYL- REMARK 900 OLIGONUCLEOTIDE BI-SUBSTRATE ANALOG WITH HNA NUCLEIC ACIDS REMARK 900 RELATED ID: 7Z5Z RELATED DB: PDB REMARK 900 7Z5Z CONTAINS THE SAME PROTEIN COMPLEXED WITH A 8-NT PEPTIDYL- REMARK 900 OLIGONUCLEOTIDE BI-SUBSTRATE ANALOG WITH DNA NUCLEIC ACIDS REMARK 900 RELATED ID: 7Z6K RELATED DB: PDB REMARK 900 7Z6K CONTAINS THE SAME PROTEIN COMPLEXED WITH A 8-NT PEPTIDYL- REMARK 900 OLIGONUCLEOTIDE BI-SUBSTRATE ANALOG WITH 2F-ANA NUCLEIC ACIDS DBREF 7Z6A A 0 335 UNP Q9EY50 FEMX_WEIVI 1 336 DBREF 7Z6A C 3 7 PDB 7Z6A 7Z6A 3 7 DBREF 7Z6A B 1 10 PDB 7Z6A 7Z6A 1 10 SEQADV 7Z6A GLY A 336 UNP Q9EY50 EXPRESSION TAG SEQADV 7Z6A HIS A 337 UNP Q9EY50 EXPRESSION TAG SEQADV 7Z6A HIS A 338 UNP Q9EY50 EXPRESSION TAG SEQADV 7Z6A HIS A 339 UNP Q9EY50 EXPRESSION TAG SEQADV 7Z6A HIS A 340 UNP Q9EY50 EXPRESSION TAG SEQADV 7Z6A HIS A 341 UNP Q9EY50 EXPRESSION TAG SEQADV 7Z6A HIS A 342 UNP Q9EY50 EXPRESSION TAG SEQRES 1 A 343 MET PRO VAL LEU ASN LEU ASN ASP PRO GLN ALA VAL GLU SEQRES 2 A 343 ARG TYR GLU GLU PHE MET ARG GLN SER PRO TYR GLY GLN SEQRES 3 A 343 VAL THR GLN ASP LEU GLY TRP ALA LYS VAL LYS ASN ASN SEQRES 4 A 343 TRP GLU PRO VAL ASP VAL TYR LEU GLU ASP ASP GLN GLY SEQRES 5 A 343 ALA ILE ILE ALA ALA MET SER MET LEU LEU GLY ASP THR SEQRES 6 A 343 PRO THR ASP LYS LYS PHE ALA TYR ALA SER LYS GLY PRO SEQRES 7 A 343 VAL MET ASP VAL THR ASP VAL ASP LEU LEU ASP ARG LEU SEQRES 8 A 343 VAL ASP GLU ALA VAL LYS ALA LEU ASP GLY ARG ALA TYR SEQRES 9 A 343 VAL LEU ARG PHE ASP PRO GLU VAL ALA TYR SER ASP GLU SEQRES 10 A 343 PHE ASN THR THR LEU GLN ASP HIS GLY TYR VAL THR ARG SEQRES 11 A 343 ASN ARG ASN VAL ALA ASP ALA GLY MET HIS ALA THR ILE SEQRES 12 A 343 GLN PRO ARG LEU ASN MET VAL LEU ASP LEU THR LYS PHE SEQRES 13 A 343 PRO ASP ALA LYS THR THR LEU ASP LEU TYR PRO SER LYS SEQRES 14 A 343 THR LYS SER LYS ILE LYS ARG PRO PHE ARG ASP GLY VAL SEQRES 15 A 343 GLU VAL HIS SER GLY ASN SER ALA THR GLU LEU ASP GLU SEQRES 16 A 343 PHE PHE LYS THR TYR THR THR MET ALA GLU ARG HIS GLY SEQRES 17 A 343 ILE THR HIS ARG PRO ILE GLU TYR PHE GLN ARG MET GLN SEQRES 18 A 343 ALA ALA PHE ASP ALA ASP THR MET ARG ILE PHE VAL ALA SEQRES 19 A 343 GLU ARG GLU GLY LYS LEU LEU SER THR GLY ILE ALA LEU SEQRES 20 A 343 LYS TYR GLY ARG LYS ILE TRP TYR MET TYR ALA GLY SER SEQRES 21 A 343 MET ASP GLY ASN THR TYR TYR ALA PRO TYR ALA VAL GLN SEQRES 22 A 343 SER GLU MET ILE GLN TRP ALA LEU ASP THR ASN THR ASP SEQRES 23 A 343 LEU TYR ASP LEU GLY GLY ILE GLU SER GLU SER THR ASP SEQRES 24 A 343 ASP SER LEU TYR VAL PHE LYS HIS VAL PHE VAL LYS ASP SEQRES 25 A 343 ALA PRO ARG GLU TYR ILE GLY GLU ILE ASP LYS VAL LEU SEQRES 26 A 343 ASP PRO GLU VAL TYR ALA GLU LEU VAL LYS ASP GLY HIS SEQRES 27 A 343 HIS HIS HIS HIS HIS SEQRES 1 C 5 ALA FGA CYS DAL DAL SEQRES 1 B 8 GF2 GF2 CFZ CFZ AF2 CFZ CFZ A9Z HET FGA C 4 9 HET DAL C 6 5 HET DAL C 7 6 HET GF2 B 1 24 HET GF2 B 2 23 HET CFZ B 5 20 HET CFZ B 6 20 HET AF2 B 7 22 HET CFZ B 8 20 HET CFZ B 9 20 HET A9Z B 10 28 HET GOL A 401 6 HET UDP A 402 24 HET MUB C 101 19 HETNAM FGA GAMMA-D-GLUTAMIC ACID HETNAM DAL D-ALANINE HETNAM GF2 2'-DEOXY-2'-FLUOROGUANOSINE 5'-(DIHYDROGEN PHOSPHATE) HETNAM CFZ 2'-DEOXY-2'-FLUOROCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) HETNAM AF2 2'-DEOXY-2'-FLUOROADENOSINE 5'-(DIHYDROGEN PHOSPHATE) HETNAM A9Z 2'-DEOXY-2'-(4-ETHYL-1H-1,2,3-TRIAZOL-1-YL)ADENOSINE HETNAM 2 A9Z 5'-(DIHYDROGEN PHOSPHATE) HETNAM GOL GLYCEROL HETNAM UDP URIDINE-5'-DIPHOSPHATE HETNAM MUB N-ACETYL-ALPHA-MURAMIC ACID HETSYN FGA D-GLUTAMIC ACID HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN MUB N-ACETYL-MURAMIC ACID; N-ACETYLMURAMIC ACID FORMUL 2 FGA C5 H9 N O4 FORMUL 2 DAL 2(C3 H7 N O2) FORMUL 3 GF2 2(C10 H13 F N5 O7 P) FORMUL 3 CFZ 4(C9 H13 F N3 O7 P) FORMUL 3 AF2 C10 H13 F N5 O6 P FORMUL 3 A9Z C14 H19 N8 O6 P FORMUL 4 GOL C3 H8 O3 FORMUL 5 UDP C9 H14 N2 O12 P2 FORMUL 6 MUB C11 H19 N O8 FORMUL 7 HOH *134(H2 O) HELIX 1 AA1 ASP A 7 SER A 21 1 15 HELIX 2 AA2 GLN A 25 ASP A 29 5 5 HELIX 3 AA3 LEU A 30 LYS A 36 1 7 HELIX 4 AA4 ASP A 83 ASP A 99 1 17 HELIX 5 AA5 SER A 114 HIS A 124 1 11 HELIX 6 AA6 ALA A 136 ALA A 140 5 5 HELIX 7 AA7 THR A 153 PHE A 155 5 3 HELIX 8 AA8 THR A 160 TYR A 165 5 6 HELIX 9 AA9 PRO A 166 ASP A 179 1 14 HELIX 10 AB1 SER A 188 HIS A 206 1 19 HELIX 11 AB2 PRO A 212 PHE A 223 1 12 HELIX 12 AB3 TYR A 266 THR A 282 1 17 HELIX 13 AB4 ASP A 299 VAL A 307 1 9 HELIX 14 AB5 ASP A 325 VAL A 333 1 9 SHEET 1 AA1 6 GLU A 40 GLU A 47 0 SHEET 2 AA1 6 ILE A 53 GLY A 62 -1 O MET A 57 N VAL A 44 SHEET 3 AA1 6 LYS A 69 ALA A 73 -1 O PHE A 70 N GLY A 62 SHEET 4 AA1 6 ALA A 102 PHE A 107 1 O ARG A 106 N ALA A 73 SHEET 5 AA1 6 GLU A 319 VAL A 323 -1 O ILE A 320 N PHE A 107 SHEET 6 AA1 6 VAL A 127 ARG A 129 -1 N VAL A 127 O ASP A 321 SHEET 1 AA2 7 VAL A 181 GLY A 186 0 SHEET 2 AA2 7 MET A 228 ARG A 235 -1 O ILE A 230 N GLY A 186 SHEET 3 AA2 7 LYS A 238 TYR A 248 -1 O SER A 241 N ALA A 233 SHEET 4 AA2 7 LYS A 251 SER A 259 -1 O TYR A 256 N ILE A 244 SHEET 5 AA2 7 LEU A 286 GLY A 291 1 O ASP A 288 N TYR A 254 SHEET 6 AA2 7 LEU A 146 ASP A 151 -1 N LEU A 150 O TYR A 287 SHEET 7 AA2 7 ARG A 314 GLU A 315 -1 O ARG A 314 N ASN A 147 LINK PB UDP A 402 O1 MUB C 101 1555 1555 1.56 LINK C ALA C 3 N FGA C 4 1555 1555 1.23 LINK N ALA C 3 C10 MUB C 101 1555 1555 1.43 LINK CD FGA C 4 N CYS C 5 1555 1555 1.38 LINK C CYS C 5 N DAL C 6 1555 1555 1.33 LINK SG CYS C 5 C7T A9Z B 10 1555 1555 1.85 LINK C DAL C 6 N DAL C 7 1555 1555 1.33 LINK O3' GF2 B 1 P GF2 B 2 1555 1555 1.61 LINK O3' CFZ B 5 P CFZ B 6 1555 1555 1.61 LINK O3' CFZ B 6 P AF2 B 7 1555 1555 1.61 LINK O3' AF2 B 7 P CFZ B 8 1555 1555 1.66 LINK O3' CFZ B 8 P CFZ B 9 1555 1555 1.61 LINK O3' CFZ B 9 P A9Z B 10 1555 1555 1.61 CISPEP 1 GLY A 76 PRO A 77 0 -4.75 CRYST1 41.900 100.880 44.290 90.00 110.65 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023866 0.000000 0.008995 0.00000 SCALE2 0.000000 0.009913 0.000000 0.00000 SCALE3 0.000000 0.000000 0.024129 0.00000